Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on AZT Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis of (2S-trans)-3-amino-2-methyl-4-oxo-1-azacyclobutyl sulfonic acid avoiding toxic chlorosulfonic acid. Enhanced safety and scalability for API manufacturing.
Discover a streamlined preparation method for Aztreonam intermediates using ion exchange resin catalysis. Achieve higher yields and reduced production cycles for reliable pharmaceutical supply chains.
Patent CN1066658A details efficient asymmetric synthesis of antiviral furanoside intermediates, offering scalable routes for HIV therapeutic manufacturing.
Patent CN100486964C details a novel synthesis for (2S-trans)-3-amino-2-methyl-4-oxo-1-azacyclobutyl sulfonic acid, replacing toxic chlorosulfonic acid with safer reagents for scalable pharmaceutical manufacturing.